CRM1(染色体区域维护蛋白 1;Exportin 1;XPO1)是核转运蛋白 β 家族转运受体的成员,是一种重要的核蛋白输出受体,可识别疏水性、富含亮氨酸的核输出信号 (NES) 并跨 Ran-GTP 梯度转运靶蛋白。CRM1 参与多种货物蛋白的主动转运,包括转录因子、肿瘤抑制蛋白 (TSP) 和细胞周期调节剂,如 p53、p21、p27、核磷蛋白 1 (NPM1),以及 RNA 分子。
CRM1 异常上调可产生多种促癌后果。CRM1 上调将允许更多生长调节蛋白(如 c-myc 或 BCR-ABL)转运到细胞质中并激活下游信号,从而导致持续的细胞增殖。类似地,肿瘤抑制蛋白 (TSP),例如 Rb、p53、p21 或 p27,在输出时功能失活,从而消除了对不适当细胞生长的检查。类似的破坏也会发生在细胞凋亡、DNA 损伤修复、染色体稳定和血管生成等过程中,仅举几个例子。因此,抑制 CRM1 活性成为一个有吸引力的治疗靶点。
CRM1 (Chromosome region maintenance 1; Exportin 1; XPO1), a member of the karyopherin β family of transport receptors, is an important nuclear protein export receptor that recognizes hydrophobic, leucine-rich nuclear export signal (NES) and transports target proteins across a Ran-GTP gradient. CRM1 is involved in the active transport of a number of cargo proteins, including transcription factors, tumor suppressor proteins (TSPs), and cell-cycle regulators, such as p53, p21, p27, nucleophosmin 1 (NPM1), as well as RNA molecules.
Abnormal CRM1 upregulation can have several cancer-promoting consequences. Upregulation of CRM1 would allow more growth regulatory proteins, such as c-myc or BCR-ABL, to be transported into the cytoplasm and activate downstream signaling leading to sustained cell proliferation. Similarly, tumor suppressor proteins (TSPs), such as Rb, p53, p21, or p27, are functionally inactivated upon export, hence removing the check on inappropriate cell growth. Similar disruptions would occur in the processes of apoptosis, DNA damage repair, chromosomal stabilization, and angiogenesis, just to name a few examples. Hence, inhibition of CRM1 activity became an attractive therapeutic target.
(E)-Selinexor ((E)-KPT-330) 是 Selinexor (MS-T21773) 的 E 构型,而 Selinexor 是一种口服有效的 CRM1 选择性抑制剂。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号